Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices

British Journal of Pharmacology

Volumn 127, Issue 3, 1999, Pages 729-739

  Latini, Serena ^a   Bordoni, Francesca ^a   Pedata, Félicita ^a   Corradetti, Renato ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

8 PT; A1 receptors; Adenosine; Adenosine deaminase; Anoxia; DPCPX; Hippocampal slices; In vitro ischaemia; Synaptic responses

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 PHENYLTHEOPHYLLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; NEUROTRANSMITTER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; EXTRACELLULAR SPACE; HIPPOCAMPUS; ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION; TIME;

ADENOSINE; ANIMALS; BRAIN ISCHEMIA; EXTRACELLULAR SPACE; HIPPOCAMPUS; KINETICS; MALE; OXYGEN; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; SYNAPTIC TRANSMISSION; THEOPHYLLINE; XANTHINES;

EID: 0033065893     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702591     Document Type: Article

References (51)

1. ALZHEIMER, C., KARGL, L. & TEN-BRUGGENCATE, G. (1991). Adenosinergic inhibition in hippocampus is mediated by adenosine A! receptors very similar to those of peripheral tissue. Ear. J. PharmacoL. 196, 313-317.
2. ANDINE, P., RUDOLPHI, K.A., FREDHOLM, B.B. & HAGBERG, H. 1(1990). Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia. Br. J. PharmacoL, 100, 814-818.
3. BALLARIN, M., FREDHOLM, B.B., AMBROSIO, S. & MAHY, N. (1991). Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol. Scand.. 142, 97-103.
4. BARLOW, R.B. (1995). Use of an antagonist for estimating the degree of agonist stimulation during physiological release. Trends PharmacoL Sei., 16, 262-264.
5. BEN ARI, Y. (1989). Effect of glibenclamide, a selective blocker of an ATP-K+ channel, on the anoxic response of hippocampal neurones. Pügers Arch., 414 (Suppl 1), SI 11 -SI 14.
6. BRUNDEGE, J.M. &. DUNWIDDIE, T.V. (1996). Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. J. Neurosci., 16, 56035612.
7. CANHaO, P., DE MENDONÇA, A. & RIBEIRO, J.A. (1994). 1,3Dipropyl-8-cycIopentylxanthine attenuates the NMDA response to hypoxia in the rat hippocampus. Brain Res., 661, 265-273.
8. CORRADETTI, R., LO CONTE, G., MORONI, F., PASSANI, M.B. & PEPEU, G. (1984a). Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur. J. PharmacoL, 104,1926.
9. CORRADETTI, R., MONETI, G., MORONI, F., PEPEU, G. & WIERASZK.O, A. (1983). Electrical stimulation of the stratum radiatum increases the release and neosynthesis of aspartate, glutamate, and gamma-aminobutyric acid in rat hippocampal slices. J. Neiirochem., 41, 1518-1525.
10. CORRADETTI, R., MORONI, F., PASSANI, M.B. & PEPEU, G. (1984b). 8-Phenyltheophylline potentiates the electrical activity evoked in hippocampal slices. Eur. J. PharmacoL, 103, 177-180.
11. CUNHA, R.A., JOHANSSON, B., VAN DER PLOEG, I., SEBASTIAO, A.M., RIBEIRO, J.A. & FREDHOLM, B.B. (1994). Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res., 649, 208-216.
12. DIXON, A.K., GUB1TZ, A.K., SIR1NATHSINGHJI, D.J.S., RICHARD-SON, P.J. & FREEMAN, T.C. (1996). Tissue distribution of adenosine receptor mRNAs in the rat. Br. J. Pharmacol., 118, 1461-1468.
13. DOMENICI, M.R., SCOTTI DE CAROLIS, A. & SAGRATELLA, S. (1996). Block by N6-L-phenylisopropyl-adenosine of the electrophysiological and morphological correlates of hippocampal ischaemic injury in the gerbil. Br. J. Pharmacol., 118,1551-1557.
14. DUNWIDDIE, T.V. (1985). The physiological roles of adenosine in the central nervous system. In International Review of Neurobiology, eds. Smythies, J.R. & Bradley, R.J. pp. 63-139. London: Academic Press.
15. DUNWIDDIE, T.V. & DIAO, L. (1994). Extracellular adenosine concentration in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses. J. Pharmacol. Exp. Ther., 268, 537-545.
16. DUNWIDDIE, T.V., DIAO, L., KIM, H.O., JIANG, J.-L. & JACOBSON, K.A. (1997). Activation of hippocampal adenosine A3 receptors produces a desensitization of AI receptor-mediated responses in rat hippocampus. J. Neurosci., 17, 607-614.
17. DUNWIDDIE, T.V. & FREDHOLM, B.B. (1989). Adenosine AI receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. J. Pharmacol. Exp. Ther.. 249, 31-37.
18. DUNWIDDIE, T.V. & HOFFER, B.J. (1980). Adenine nucleotide and synaptic transmission in the in vitro rat hippocampus. Br. J. Pharmacol., 69, 59-68.
19. DUNWIDDIE, T.V., WORTH, T.S. & OLSSON, R.A. (1986). Adenosine analogs mediating depressant effects on synaptic transmission in rat hippocampus: structure-activity relationship for the N6 subregion. Naunyn-Schmiedeberg1 s Arch. Pharmacol., 334, 77 85.
20. DUX, E., FASTBOM, J., UNGERSTEDT, U., RUDOLPHI, K. & FREDHOLM, B.B. (1990). Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res., 516, 248-256.
21. FOWLER, J.C. (1989). Adenosine antagonists delay hypoxia-induced depression of neuronal activity in hippocampal brain slice. Brain Res., 490, 378-384.
22. FOWLER, J.C. (1990). Adenosine antagonists alter the synaptic response to in vitro ischaemia in the rat hippocampus. Brain Res., 509,331-334.
23. FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DALY, J.W., HARDEN, K., JACOBSON, K.A., LEFF, P. & WILLIAMS, M. 1(1994). Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.
24. HAGBERG, H., ANDERSSON, P., LACAREWICZ, I., JACOBSON, I., BUTCHER, S. & SANDBERG, M. (1987). Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleosides and purines in rat striatum during transient ischemia. J. Neurochem., 49, 227-231.
25. HERON, A., LEKIEFFRE, D., LE PEILLET, E., FASBENNES, F., SEYLAZ, J., PLOTKINE, M. & BOULU, R.G. (1994). Effects of an A| adenosine receptor agonist on the neurochemical, behavioural and histological consequences of ischemia. Brain Res., 641,217224.
26. HUBBARD, J.I., LLINaS, R. & QUASTEL, D.M.J. (1969). Electrophysiological analysis of synaptic transmission, eds. Davson, H., Greenfield, A.D.M., VVhittam, R. & Brindley, O.S. pp. 1-368. London: Edward Arnold.
27. KENAKIN, T. (1993). Pharmacologie analysis of drug-receptor interaction, pp. 1-484. New York: Raven Press.
28. LATINI, S., BORDONI, F., CORRADETTI, R., PEPEU, G. & PEDATA, F. (1998a). Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions. Brain Res., 794, 325-328.
29. LATINI, S., BORDONI, F., CORRADETTI, R., PEPEU, G. & PEDATA, F. (1998b). The A2A adenosine receptor agonist COS 21680 reduces the synaptic depression induced by in vitro ischemia in rat hippocampal slices. Drug. Dev. Res., 43, 213.
30. LUCCHI, R., LATINI, S., DE MENDONCA, A., SEBASTIÄO, A.M. & RIBEIRO, J.A. (1996). Adenosine by activating AI receptors prevents GABAA-mediated actions during hypoxia in the rat hippocampus. Brain Res., 732, 261 -266.
31. MOURRE, C, BEN ARI, Y., BERNARDI, H., FOSSET, M. & LAZDUNSKI, M. (1989). Antidiabetic sulfonylureas: localization of binding sites in the brain and effect on the hyperpolarization induced by anoxia in hippocampal slices. Brain Res., 486, 159164.
32. O1 KANE, E.M. & STONE, T.W. (1998). Interaction between adenosine Al and A2 receptor-mediated responses in the rat hippocampus in vitro. Eur. J. Pharmacol., 362, 17-25.
33. O1 REGAN, M.H., SIMPSON, R.E., PERKINS, L.M. & PHILLIS, J.W. (1992). The selective A2 adenosine receptor agonist COS 21680 enhances excitatory transmitter amino acid release from the ischémie rat cerebral cortex. Neurosci. Lett., 138, 169-172.
34. PAZZAGLI, M., CORSI, C., FRATTI, S., PEDATA, F. & PEPEU, G. (1995). Regulation of extracellular adenosine levels in the striatum of aging rats. Brain Res., 684, 103-106.
35. PAZZAGLI, M., CORSI, C., LATINI, S., PEDATA, F. & PEPEU, G. (1994). In vivo regulation of extracellular adenosine levels in the cerebral cortex by NMDA and muscarinic receptors. Eur. J. Pharmacol.. 254, 277-282.
36. PAZZAGLI, M., PEDATA, F. & PEPEU, G. (1993). Effect of K + depolarisation, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum. Eur. J. Pharmacol., 234,61-65.
37. PEDATA, F., LATINI, S., PUGLIESE, A.M. & PEPEU, G. (1993). Investigation into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J. Neureichem., 61,284-289.
38. PEDATA, F., PAZZAGLI, M. & PEPEU, G. (1991). Endogenous adenosine release from hippocampal slices: excitatory amino acid agonists stimulate release, antagonists reduce the electrically-evoked release. Naunyn-Schmiedeberg1 s Arch. Pharmacol., 344,538-543.
39. PHILLIS, J.W. (1989). Adenosine in the control of the cerebral circulation. Cerebrovasc. Brain Metab. Re\\, 1, 26-54.
40. PHILLIS, J.W., WALTER, G.A., O1 REGAN, M.H. & STAIR, R.E. (1987). Increases in cerebral cortical perfusate adenosine and inosine concentrations during hypoxia and ischemia. J. Cereb. Blood Flow Afetab., 7, 619-686.
41. PRINCE, D.A. & STEVENS, C.F. (1992). Adenosine decreases neurotransmitter release at central synapses. Proc. Nail. Acad. Sei. U.S.A., 89, 8586-8590.
42. PROCTOR, W.R. & DUNWIDDIE, T.V. (1987). Pre- and postsynaptic actions of adenosine in the in vitro rat hippocampus. Brain Res., 426, 187-190.
43. RUDOLPHI, K.A., SCHUBERT, P., PARKINSON, F.E. & FREDHOLM, B.B. (1992). Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sei., 13, 439-445.
44. SCHOLZ, K.P. & MILLER, R.J. (1992). Inhibition of quantal transmitter release in the absence of calcium influx by a G protein-linked adenosine receptor at hippocampal synapses. Neuron, 1139-1150.
45. SCHUBERT, P. (1988). Physiological modulation by adenosine: selective blockade of Apreceptors with DPCPX enhances stimulus train-evoked neuronal Ca+ + influx in rat hippocampal slices. Brain Res.. 458, 162-165.
46. SEBASTIaO, A.M. & RIBEIRO, J.A. (1992). Evidence for the presence of excitatory A2 adenosine receptors in the rat hippocampus. Neurosci. Lett.. 138, 41-44.
47. SEBASTIaO, A.M., STONE, T.W. & RIBEIRO, J.A. (1990). The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br. J. Pharmacol., 101, 453-459.
48. TROMBA, C., SALVAGGIO, A., RACAGNI, G. & VOLTERRA, A. (1992). Hypoglycemia-activated K+ channels in hippocampal neurons. Neurosci. Lett., 143, 185-189.
49. VON LUBITZ, O.K., LIN, R.C., POPIK, P., CARTER, M.F. & JACOBSON, K.A. (1994). Adenosine A3 receptor stimulation and cerebral ischemia. EUT. J. Pharmacol., 263, 59-67.
50. WU, L.-G. & SAGGAU, P. (1994). Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron, 12, 1139-1148.
51. ZOCCHI, C, ONGINI, E., CONTI, A.M., MONOPOLI, A., NEGRETTI, A., BARALDI, P.O. & DIONISOTTI, S. (1996). The non-xanthine heterocycling compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. J. Pharmacol. Exp. Ther., 276,398-404.